157 related articles for article (PubMed ID: 8691351)
1. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
[TBL] [Abstract][Full Text] [Related]
2. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
Umeki K; Yamamoto I; Maruta J; Aratake Y; Ono I; Uemura Y; Tanaka T; Toyoda K; Kotani T; Noguchi S; Sakamoto F; Konoe K; Ohtaki S
Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
[TBL] [Abstract][Full Text] [Related]
3. Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?
Czarnocka B; Pastuszko D; Janota-Bzowski M; Weetman AP; Watson PF; Kemp EH; McIntosh RS; Asghar MS; Jarzab B; Gubala E; Wloch J; Lange D
Br J Cancer; 2001 Sep; 85(6):875-80. PubMed ID: 11556840
[TBL] [Abstract][Full Text] [Related]
4. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
Fernández PL; Merino MJ; Gómez M; Campo E; Medina T; Castronovo V; Sanjuán X; Cardesa A; Liu FT; Sobel ME
J Pathol; 1997 Jan; 181(1):80-6. PubMed ID: 9072007
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of differentiation- and dedifferentiation markers in normal and malignant human thyroid tissues.
Hoang-Vu C; Dralle H; Scheumann G; Maenhaut C; Horn R; von zur Mühlen A; Brabant G
Exp Clin Endocrinol; 1992; 100(1-2):51-6. PubMed ID: 1281780
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues.
Umeki K; Tanaka T; Yamamoto I; Aratake Y; Kotani T; Sakamoto F; Noguchi S; Ohtaki S
Endocr J; 1996 Feb; 43(1):53-60. PubMed ID: 8732452
[TBL] [Abstract][Full Text] [Related]
9. Thyroid peroxidase expression and DNA polymorphisms in thyroid cancer.
Smanik PA; Fithian LJ; Jhiang SM
Biochem Biophys Res Commun; 1994 Feb; 198(3):948-54. PubMed ID: 8117301
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous distribution of thyrotrophin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinomas detected by in situ hybridization.
Tanaka K; Inoue H; Miki H; Komaki K; Monden Y
Clin Endocrinol (Oxf); 1996 Mar; 44(3):259-67. PubMed ID: 8729520
[TBL] [Abstract][Full Text] [Related]
11. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.
Elisei R; Pinchera A; Romei C; Gryczynska M; Pohl V; Maenhaut C; Fugazzola L; Pacini F
J Clin Endocrinol Metab; 1994 Apr; 78(4):867-71. PubMed ID: 8157713
[TBL] [Abstract][Full Text] [Related]
12. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
Weber KB; Shroyer KR; Heinz DE; Nawaz S; Said MS; Haugen BR
Am J Clin Pathol; 2004 Oct; 122(4):524-31. PubMed ID: 15487449
[TBL] [Abstract][Full Text] [Related]
13. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
de Souza Meyer EL; Dora JM; Wagner MS; Maia AL
Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828
[TBL] [Abstract][Full Text] [Related]
14. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
15. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of RASSF1A, Galectin-3 and TPO mRNA in papillary thyroid carcinoma and their clinical significance].
Xu MR; Chen Y; Zhou SR; Chi MM; Chen SL; Liu LY
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):356-60. PubMed ID: 19799084
[TBL] [Abstract][Full Text] [Related]
17. In situ hybridization and immunohistochemistry study of thyroid peroxidase expression in thyroid tumors.
De Micco C; Kopp F; Vassko V; Grino M
Thyroid; 2000 Feb; 10(2):109-15. PubMed ID: 10718546
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical demonstration of thyroid peroxidase (TPO) in human thyroid tissues from various thyroid diseases.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Arai Y; Kotani T; Ohtaki S; Matsukawa S
Anticancer Res; 1994; 14(3B):1329-34. PubMed ID: 8067701
[TBL] [Abstract][Full Text] [Related]
19. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin: a differentiation marker in thyroid malignancies.
Brabant G; Hoang-Vu C; Cetin Y; Dralle H; Scheumann G; Mölne J; Hansson G; Jansson S; Ericson LE; Nilsson M
Cancer Res; 1993 Oct; 53(20):4987-93. PubMed ID: 8402689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
